Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Short Communication, Mol Med Ther Vol: 1 Issue: 2
Novel Combinatorial Therapeutic Targeting of PAI-1(SERPINE1) Gene Expression in Alzheimer’s Disease
| Stacie M. Kutz1, Craig E. Higgins2 and Paul J. Higgins2* |
| 1Department of Biology, Sage College of Albany, Albany, NY 12208, USA |
| 2Center for Cell Biology & Cancer Research, Albany Medical College 47 New Scotland Avenue, Albany, NY 12208, USA |
| Corresponding author : Dr. Paul J. Higgins Center for Cell Biology & Cancer Research, Albany Medical College 47 New Scotland Avenue, Albany, NY 12208, USA E-mail: higginp@mail.amc.edu |
| Received: November 06, 2012 Accepted: December 10, 2012 Published: December 13, 2012 |
| Citation: Kutz SM, Higgins CE, Higgins PJ (2012) Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer’s Disease. Mol Med Ther 1:2. doi:10.4172/2324-8769.1000106 |
Abstract
Novel Combinatorial Therapeutic Targeting of PAI-1(SERPINE1) Gene Expression in Alzheimer’s Disease
Accumulation of neurotoxic amyloid peptides (Aβ) in the brain, generated by β-site proteolytic processing of the amyloid precursor protein (APP), is the hallmark pathophysiologic feature of Alzheimer’s disease. The plasmin-activating cascade, in which urokinase (uPA) and tissue-type (tPA) plasminogen activators convert plasminogen to the broad-spectrum protease plasmin, appears to serve a protective, Aβ-clearing, role in the central nervous system.